APA (7th ed.) Citation

Mishra, S. K., Kumar, P., Khullar, S., Joshi, A., Sati, A., Kumar, S. V., . . . Kumar, A. (2022). Efficacy and safety of brolucizumab versus aflibercept in patients with neovascular age-related macular degeneration: A randomized trial in Indian patients. BMC.

Chicago Style (17th ed.) Citation

Mishra, Sanjay Kumar, Pradeep Kumar, Srishti Khullar, Amrita Joshi, Alok Sati, Sonali Vinay Kumar, Deepesh Unni, and Atul Kumar. Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients with Neovascular Age-related Macular Degeneration: A Randomized Trial in Indian Patients. BMC, 2022.

MLA (9th ed.) Citation

Mishra, Sanjay Kumar, et al. Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients with Neovascular Age-related Macular Degeneration: A Randomized Trial in Indian Patients. BMC, 2022.